Alzheimer’s Drugs Market to Surge beyond US$ 15 Billion by 2025

1
(No Transcript)
2

• REPORT DESCRIPTION

Global Alzheimers Drugs Market
Overview Increasing prevalence of Alzheimers
disease to drive growth of the Alzheimers drugs
market worldwide Increasing prevalence and
incidence of Alzheimers disease worldwide is
expected to drive the growth of Alzheimers
disease therapeutics market. According to World
Alzheimer Report in 2016, an estimated 46.5
million people were suffering from Alzheimers
disease and the number is projected to reach 50
million by 2017, every three second there is new
patient of Alzheimers disease worldwide. Increasi
ng age and aging global population are major risk
factors for Alzheimers, which increase the
disease incidence and provide growth opportunity
for Alzheimers treatment market. For instance,
according to World Population Prospects (WPP)
published by United Nations in 2017, an estimated
962 million people are of age 60 or above, which
accounted for 13 per cent of the global
population. The number is projected to reach 1.4
billion by 2030, growing with annual rate of 3
percent. Europe currently has highest geriatric
population (25 of population), Asia Pacific had
geriatric population of 547 million people and it
is projected to reach 900 million by 2025,
therefore these regions have potential
opportunity for growth of the market. India has
more than 1 million cases of Alzheimers disease
annually. North America holds dominant position
in the Alzheimers disease therapeutics market
with estimated 5.5. Mn patients in 2017. The
robust healthcare infrastructure in the region,
and the region being an early adopter of novel
technologies, positions it as a major market for
Alzheimers disease.
3
REPORT DESCRIPTION

• Global Alzheimers drugs market Taxonomy
• Global Alzheimers Drugs Market, By Drugs
• Donepezil
• Rivastigmine
• Galantamine
• Memantine
• Global Alzheimers Drugs Market, By Distribution
  Channel
• Hospital Pharmacies
• Retail Pharmacies
• e-Commerce
• Ask for detailed Sample of the Research Report _at_
  https//www.coherentmarketinsights.com/insight/req
  uest-sample/1373
• The Sample consists of Table of Content,
  Research framework of the actual report
  research methodology adopted for it.

4
REPORT DESCRIPTION
Global Alzheimers drugs market Taxonomy Global
Alzheimers Drugs Market, By Geography North
America Latin America Europe Asia Pacific Middle
East Africa Click here to know more about this
publish report https//www.coherentmarketinsights
.com/market-insight/alzheimers-drugs-market-1373
5
REPORT DESCRIPTION

• Global Alzheimers drugs market Key Players
• Major players involved in the global Alzheimers
  drugs market include
• Pfizer, Inc.
• Janssen Pharmaceutical
• Novartis International AG
• Eisai Co. Ltd.
• Lundbeck A/S
• Teva Pharmaceuticals Industries Ltd.
• Eli Lilly and Company
• TauRx Pharmaceuticals Ltd
• VTV Therapeutics
• Hoffman-La Roche Ltd.
• AstraZeneca plc
• AC Immune.

6
(No Transcript)
7
(No Transcript)
8
(No Transcript)
9
THANK YOU
To know more about us, visit our website
www.coherentmarketinsights.com For sales
queries or new topics email us on
sales_at_coherentmarketinsights.com For other
queries contact Mr. Shah (Manager - Business Deve
lopment) Coherent Market Insights sales_at_coherentm
arketinsights.com 1-206-701-6702